Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Sci Rep ; 11(1): 17982, 2021 09 09.
Article in English | MEDLINE | ID: mdl-34504250

ABSTRACT

We recently highlighted a novel potential protective paracrine role of cardiac myeloid CD11b/c cells improving resistance of adult hypertrophied cardiomyocytes to oxidative stress and potentially delaying evolution towards heart failure (HF) in response to early ß-adrenergic stimulation. Here we characterized macrophages (Mφ) in hearts early infused with isoproterenol as compared to control and failing hearts and evaluated the role of upregulated CX3CL1 in cardiac remodeling. Flow cytometry, immunohistology and Mφ-depletion experiments evidenced a transient increase in Mφ number in isoproterenol-infused hearts, proportional to early concentric hypertrophy (ECH) remodeling and limiting HF. Combining transcriptomic and secretomic approaches we characterized Mφ-enriched CD45+ cells from ECH hearts as CX3CL1- and TNFα-secreting cells. In-vivo experiments, using intramyocardial injection in ECH hearts of either Cx3cl1 or Cx3cr1 siRNA, or Cx3cr1-/- knockout mice, identified the CX3CL1/CX3CR1 axis as a protective pathway delaying transition to HF. In-vitro results showed that CX3CL1 not only enhanced ECH Mφ proliferation and expansion but also supported adult cardiomyocyte hypertrophy via a synergistic action with TNFα. Our data underscore the in-vivo transient protective role of the CX3CL1/CX3CR1 axis in ECH remodeling and suggest the participation of CX3CL1-secreting Mφ and their crosstalk with CX3CR1-expressing cardiomyocytes to delay HF.


Subject(s)
Adrenergic beta-Agonists/adverse effects , CX3C Chemokine Receptor 1/metabolism , Chemokine CX3CL1/metabolism , Heart Failure/chemically induced , Heart Failure/metabolism , Isoproterenol/adverse effects , Macrophages/metabolism , Myocytes, Cardiac/metabolism , Signal Transduction/genetics , Animals , CX3C Chemokine Receptor 1/genetics , Cell Communication/genetics , Cell Proliferation/genetics , Cells, Cultured , Chemokine CX3CL1/genetics , Disease Models, Animal , Heart Failure/genetics , Hypertrophy , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myocytes, Cardiac/pathology , RNA, Small Interfering/administration & dosage , RNA, Small Interfering/genetics , Tumor Necrosis Factor-alpha/metabolism , Ventricular Remodeling/genetics
2.
Gene Ther ; 20(9): 901-12, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23535897

ABSTRACT

Coronary artery disease represents the leading cause of mortality in the developed world. Percutaneous coronary intervention involving stent placement remains disadvantaged by restenosis or thrombosis. Vascular gene therapy-based methods may be approached, but lack a vascular gene delivery vector. We report a safe and efficient long-term transduction of rat carotid vessels after balloon injury intervention with a translational optimized AAV2.5 vector. Compared with other known adeno-associated virus (AAV) serotypes, AAV2.5 demonstrated the highest transduction efficiency of human coronary artery vascular smooth muscle cells (VSMCs) in vitro. Local delivery of AAV2.5-driven transgenes in injured carotid arteries resulted in transduction as soon as day 2 after surgery and persisted for at least 30 days. In contrast to adenovirus 5 vector, inflammation was not detected in AAV2.5-transduced vessels. The functional effects of AAV2.5-mediated gene transfer on neointimal thickening were assessed using the sarco/endoplasmic reticulum Ca(2+) ATPase isoform 2a (SERCA2a) human gene, known to inhibit VSMC proliferation. At 30 days, human SERCA2a messenger RNA was detected in transduced arteries. Morphometric analysis revealed a significant decrease in neointimal hyperplasia in AAV2.5-SERCA2a-transduced arteries: 28.36±11.30 (n=8) vs 77.96±24.60 (n=10) µm(2), in AAV2.5-green fluorescent protein-infected, P<0.05. In conclusion, AAV2.5 vector can be considered as a promising safe and effective vector for vascular gene therapy.


Subject(s)
Coronary Restenosis/therapy , Dependovirus/genetics , Genetic Therapy , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Actins/genetics , Actins/metabolism , Animals , Carotid Arteries/cytology , Cells, Cultured , Coronary Vessels/cytology , Dependovirus/physiology , Disease Models, Animal , Genetic Vectors , Humans , Male , Muscle, Smooth, Vascular/pathology , Neointima/physiopathology , Rats , Rats, Sprague-Dawley , Transduction, Genetic
3.
Gene Ther ; 20(4): 396-406, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22763406

ABSTRACT

Coronary restenosis, a major complication of percutaneous balloon angioplasty, results from neointimal proliferation of vascular smooth muscle cells (VSMCs). The sarco/endoplasmic reticulum calcium ATPase 2a isoform (SERCA2a), specific to contractile VSMCs, has been reported previously to be involved in the control of the Ca(2+)-signaling pathways governing proliferation and migration. Moreover, SERCA2a gene transfer was reported to inhibit in vitro VSMC proliferation and to prevent neointimal thickening in a rat carotid injury model. The aim of this study was to evaluate the potential therapeutic interest of SERCA2a gene transfer for prevention of in-stent restenosis using a ex vivo model of human left internal mammary artery (hIMA) intimal thickening. Left hIMAs, obtained at the time of aorto-coronary bypass surgeries, were subjected to balloon dilatation followed by infection for 30 min with adenoviruses encoding either human SERCA2 and green fluorescence protein (GFP) or control gene (ß-galactosidase, ß-gal) and GFP. Proliferation of subendothelial VSMCs and neointimal thickening were observed in balloon-injured hIMA maintained 14 days in organ culture under constant pressure and perfusion. SERCA2a gene transfer prevented vascular remodeling and significantly (P<0.01, n=5) reduced neointimal thickening in injured arteries (intima/media ratio was 0.07±0.01 vs 0.40±0.03 in ß-gal-infected arteries). These findings could have potential implications for treatment of pathological in-stent restenosis.


Subject(s)
Cell Proliferation , Genetic Therapy , Mammary Arteries/pathology , Muscle, Smooth, Vascular/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases/genetics , Tunica Intima/metabolism , Calcium/metabolism , Calcium Signaling , Coronary Restenosis/prevention & control , Coronary Restenosis/therapy , Gene Transfer Techniques , Humans , In Vitro Techniques , Muscle, Smooth, Vascular/pathology , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Tunica Intima/pathology
4.
Gene Ther ; 20(3): 248-54, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22456325

ABSTRACT

Targeting diseased cells is a challenging issue in both pharmacological and biological therapeutics. Gene therapy is emerging as a novel approach for treating rare diseases and for illnesses for which there is no other alternative. An important limitation of gene therapy has been the off-target effects and therefore efforts have been focused on increasing the specificity of gene transfer to the targeted organ. Here, we describe a promoter containing six nuclear factor of activated T cells (NFAT) consensus sequences, which is as efficient as the cytomegalovirus (CMV) promoter to drive expression in vascular smooth muscle cells both in vitro and in vivo. In contrast to the CMV promoter it is activated in a Ca(2+)-dependent manner after endoplasmic reticulum depletion and allows the transgene expression only in proliferative/diseased cells. Overexpression of sarco/endoplasmic reticulum (SR/ER) Ca(2+) ATPase 2a under the control of this NFAT promoter inhibits restenosis after angioplasty in rats. In conclusion, this promoter may be useful for gene therapy in vascular proliferative diseases and other diseases involving upregulation of the NFAT pathway.


Subject(s)
Calcium/metabolism , Genetic Therapy/methods , Myocytes, Smooth Muscle/metabolism , NFATC Transcription Factors/genetics , Promoter Regions, Genetic/genetics , Adenoviridae/genetics , Animals , Carotid Artery Injuries/genetics , Carotid Artery Injuries/therapy , Cattle , Cell Proliferation/drug effects , Cells, Cultured , Culture Media/pharmacology , Cytomegalovirus/genetics , Endoplasmic Reticulum/metabolism , Gene Expression Regulation/drug effects , Genetic Vectors/genetics , Humans , Luciferases/genetics , Luciferases/metabolism , Male , Microscopy, Confocal , Muscle, Smooth, Vascular/cytology , Rats , Rats, Wistar , Sarcoplasmic Reticulum Calcium-Transporting ATPases/genetics , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Serum
5.
J Appl Microbiol ; 103(3): 657-65, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17714399

ABSTRACT

AIMS: The purpose of this study was to investigate the antibacterial activity of the Xynotyri cheese isolate Lactobacillus plantarum ACA-DC287 using a set of in vitro and in vivo assays. METHODS AND RESULTS: The co-culture of L. plantarum strain ACA-DC287 and Salmonella enterica serovar Typhimurium strain SL1344 results in the killing of the pathogen. The killing activity was produced mainly by non-lactic acid molecule(s) that were present in the cell-free culture supernatant of the L. plantarum strain ACA-DC287. The culture of the L. plantarum strain ACA-DC287 inhibited the penetration of S. typhimurium SL1344 into cultured human enterocyte-like Caco-2/TC7 cells. In conventional mice infected with S. typhimurium SL1344, the intake of L. plantarum strain ACA-DC287 results in a decrease in the levels of Salmonella associated with intestinal tissues or those present in the intestinal contents. In germ-free mice, the L. plantarum strain ACA-DC287 colonized the gastrointestinal tract. CONCLUSIONS: The L. plantarum strain ACA-DC287 strain exerts anti-Salmonella activity similar that of the established probiotic strains Lactobacillus rhamnosus GG, Lactobacillus casei Shirota YIT9029 and Lactobacillus johnsonii La1. SIGNIFICANCE AND IMPACT OF THE STUDY: The observation that a selected cheese Lactobacillus strain exerted antibacterial activity that was similar to those of probiotic Lactobacillus strains, is of interest for the use of this strain as an adjunct strain for the production of health-giving cheeses.


Subject(s)
Cheese/microbiology , Food Microbiology , Lactobacillus plantarum/physiology , Salmonella typhimurium/physiology , Animals , Caco-2 Cells , Cell-Free System , Colony Count, Microbial , Culture Media , Female , Gastrointestinal Tract/microbiology , Humans , Mice , Mice, Inbred C3H , Probiotics/pharmacology , Salmonella Infections, Animal/microbiology
6.
Acta Neurochir (Wien) ; 149(9): 857-66; discussion 866, 2007.
Article in English | MEDLINE | ID: mdl-17624489

ABSTRACT

BACKGROUND: We investigated retrospectively the short and long-term motor and cognitive functioning of staged bilateral pallidotomy using motor testing and a comprehensive neuropsychological battery before and after each procedure. METHODS: Fifteen patients with idiopathic Parkinson's disease were assessed at baseline and at least 3 months after each of their two staged surgeries. Motor and neuropsychological results were compared to 15 non-surgical Parkinson's disease patients matched for disease stage and mental status. In addition, nine bilateral pallidotomy patients were evaluated for long-term cognitive changes (>2 years). FINDINGS: Bilateral pallidotomy patients demonstrated significant improvements in motor functioning in the "on" and "off" states and with dyskinesias after the first surgery, with an additional improvement reported for dyskinesias after the second procedure. On long-term follow-up, dyskinesia improvements were maintained. Bilateral pallidotomy patients did not show significant cognitive declines following both procedures on the short-term follow-up and when compared to the Parkinson's disease group. However, significant cognitive declines were found on the long-term follow-up evaluation. CONCLUSIONS: Parkinson's disease patients received significant short- and long-term motor benefits, particularly reduced dyskinesias, following staged bilateral pallidotomy without significant short-term cognitive consequences. Two years following the second procedure, bilateral pallidotomy patients tended to show an increase in both motor and non-motor symptoms of Parkinson's disease, particularly cognitive decline.


Subject(s)
Cognition , Movement , Pallidotomy , Parkinson Disease/physiopathology , Parkinson Disease/psychology , Activities of Daily Living , Aged , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neuropsychological Tests , Pallidotomy/adverse effects , Parkinson Disease/surgery , Reoperation , Retrospective Studies , Severity of Illness Index , Treatment Outcome
7.
J Appl Microbiol ; 101(3): 647-54, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16907815

ABSTRACT

AIMS: The purpose of this study was to investigate in vitro the antibacterial activity of the Lactobacillus helveticus strain KS300 against vaginosis-associated bacteria including Gardnerella vaginalis and Prevotella bivia, uropathogenic Escherichia coli, and diarrhoeagenic Salmonella enterica serovar Typhimurium. METHODS AND RESULTS: The KS300 strain inhibited the growth of G. vaginalis, P. bivia, S. typhimurium, and pathogenic E. coli. After direct co-culture, data show that the Lactobacillus strain decreased the viability of G. vaginalis, P. bivia, S. typhimurium, and pathogenic E. coli. The adhering KS300 strain inhibited the adhesion of G. vaginalis DSM 4944 and uropathogenic Dr-positive E. coli IH11128 onto HeLa cells. Moreover, the KS300 strain inhibited the internalization of uropathogenic Dr-positive E. coli IH11128 within HeLa cells and S. typhimurium SL1344 within Caco-2/TC7 cells. CONCLUSIONS: The findings demonstrate that L. helveticus strain KS300 is adhesive onto cultured human cells and has antagonistic activities against vaginosis-associated, uropathogenic and diarrhoeagenic pathogens. SIGNIFICANCE AND IMPACT OF THE STUDY: Adhering L. helveticus strain KS300 is a potential probiotic strain displaying a strain-specific array of in vitro antibacterial activities.


Subject(s)
Diarrhea/microbiology , Lactobacillus helveticus/physiology , Probiotics/therapeutic use , Urologic Diseases/microbiology , Vaginosis, Bacterial/microbiology , Bacterial Adhesion/physiology , Caco-2 Cells , Coculture Techniques/methods , Diarrhea/diet therapy , Escherichia coli/growth & development , Female , Gardnerella vaginalis/growth & development , HeLa Cells , Humans , Prevotella/growth & development , Salmonella typhimurium/growth & development , Urologic Diseases/diet therapy , Vaginosis, Bacterial/diet therapy
8.
J Neurol Neurosurg Psychiatry ; 76(12): 1636-9, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16291885

ABSTRACT

BACKGROUND: Excessive daytime somnolence (EDS) commonly complicates Parkinson's disease (PD). The aetiology of EDS is probably multifactorial but is probably exacerbated by dopaminergic medications. Modafinil is a wake-promoting agent approved for use in narcolepsy, but it is often used to treat a variety of somnolent conditions. METHOD: A double blind, placebo controlled parallel design trial was conducted to assess the efficacy of modafinil (200-400 mg/day) for the treatment of EDS in PD. The primary efficacy measure was the Epworth Sleepiness (ES) scale score. Secondary efficacy points included the Unified Parkinson's Disease Rating Scale (UPDRS), the Fatigue Severity Scale, the Hamilton Depression Scale, and the multiple sleep latency test (MSLT). RESULTS: Of a total of 40 subjects (29 men, mean (SD) age 64.8 (11.3) years), randomised to modafinil or placebo, 37 completed the study. Modafinil failed to significantly improve ES scores compared with placebo (2.7 v 1.5 points improvement, respectively, p = 0.28). MSLT failed to improve with modafinil relative to placebo (-0.16 v -0.70, respectively, p = 0.14). UPDRS, global impressions, Fatigue Severity Scale, and Hamilton Depression Scale scores were unchanged. Adverse events were minimal. CONCLUSION: Modafinil failed to significantly improve EDS in PD compared with placebo. The drug did not alter motor symptoms in PD and was well tolerated.


Subject(s)
Benzhydryl Compounds/therapeutic use , Central Nervous System Stimulants/therapeutic use , Disorders of Excessive Somnolence/drug therapy , Disorders of Excessive Somnolence/etiology , Parkinson Disease/complications , Parkinson Disease/drug therapy , Aged , Double-Blind Method , Female , Humans , Male , Middle Aged , Modafinil , Placebos , Severity of Illness Index , Treatment Outcome
9.
Neurology ; 57(8): 1392-6, 2001 Oct 23.
Article in English | MEDLINE | ID: mdl-11673578

ABSTRACT

BACKGROUND: PD is associated with a variety of sleep problems. The dopamine agonists (DA) pramipexole and ropinirole were recently implicated in causing "sleep attacks" and motor vehicle accidents. METHODS: In order to determine the overall rate of subjective sleep problems in PD and to determine if any factors, including specific medications, correlate with sleep pathology, the authors surveyed consecutive patients with PD seen over a 3-month period in a Movement Disorders Clinic. The authors collected demographic and medication data, and the patients completed the Epworth Sleepiness Scale (ESS), questions assessing the presence of restless legs syndrome (RLS), a modified National Sleep Foundation sleep survey, and specific questions regarding falling asleep while driving. RESULTS: A total of 320 patients completed the questionnaire. The authors eliminated 17, six for incomplete data and 11 for having a primary diagnosis other than PD. The mean age of the remaining 303 patients was 67.1 +/- 10.7 years, and the mean duration of PD was 9.1 +/- 5.7 years. The ESS scores averaged 11.1 +/- 5.9, and in 50.2% of patients the score was abnormally high (>10). Stepwise regression analysis found that sleepiness correlated with longer duration of PD (p < 0.001), more advanced PD (p < 0.004), male sex (p < 0.001), and the use of any DA (p < 0.003). The soporific effects of the three most common DA (pramipexole, ropinirole, and pergolide) were similar. Falling asleep while driving was reported by 63/279 (22.6%) of current drivers and correlated with higher ESS scores (p < 0.05). Other sleep disorders, including RLS, were also frequently reported. CONCLUSION: Daytime sleepiness is common in PD and correlates with more advanced and longer duration of PD, and male sex. The DA were also independently associated with daytime sleepiness, but in this group, no single DA was more culpable than the others.


Subject(s)
Parkinson Disease/epidemiology , Sleep Wake Disorders/epidemiology , Adult , Aged , Aged, 80 and over , Antiparkinson Agents/therapeutic use , Automobile Driving , Data Collection , Female , Humans , Male , Middle Aged , Parkinson Disease/drug therapy , Predictive Value of Tests , Prospective Studies , Risk Factors , Sleep Stages
10.
Indian J Dent Res ; 12(2): 71-6, 2001.
Article in English | MEDLINE | ID: mdl-11665399

ABSTRACT

The study was designed to assess the level of oral home-care among subjects on renal dialysis. The study included 90 subjects, 37 (41.1%) male and 53 (58.9%) female, on renal dialysis. The mean age was 45.63 +/- 16.77. Four indices were used; the plaque index (PI); the debris index (DI); the calculus index (CI) and the gingival index (GI). Results showed that all subjects did not have optimal oral hygiene, means of PI, DI, CI and GI., were 2.0444, 1.9556, 1.8944 and 1.8167 respectively. No significant differences were observed between male and female. Frequency of plaque distribution indicated that 69.9% of the individuals had poor oral hygiene. In conclusion, subjects on renal dialysis were at high risk for developing periodontal disease. It is recommended that, subjects on renal dialysis should be regularly examined by dentists for proper care.


Subject(s)
Dental Care for Chronically Ill , Oral Hygiene , Renal Dialysis , Analysis of Variance , Cross-Sectional Studies , Dental Plaque Index , Female , Humans , Male , Middle Aged , Observer Variation , Oral Hygiene Index , Periodontal Index
11.
Pharm Dev Technol ; 4(4): 467-74, 1999.
Article in English | MEDLINE | ID: mdl-10578499

ABSTRACT

The purpose of this work was to examine the sorption and desorption of water by various samples of microcrystalline cellulose, MCC (Avicel PH-101), taken from the extrusion/marumerization process, and to provide data that may explain how water affects the MCC polymer matrix during the formation of beads. Two isopiestic (humidity) studies were conducted: the first used samples exposed directly to controlled humidity conditions, whereas the second used samples that were freeze-dried before being exposed to controlled humidity conditions. Water sorption and desorption were determined gravimetrically. When both sets of samples were initially exposed to low-humidity conditions, they reached equilibrium by desorbing water. When these samples were initially exposed to high-humidity conditions, the high moisture content samples desorbed water, whereas the low moisture content and the freeze-dried samples sorbed water to reach equilibrium. When the first set of samples was initially exposed to high- and then to low-humidity conditions, they reached the same water content achieved by being equilibrated directly at the low-humidity condition. However, samples that were initially exposed to low- and then to high-humidity conditions had equilibrium water contents that were lower than those achieved by being equilibrated directly at the high-humidity condition. The original MCC systems exhibit a hysteretic effect above 85%, whereas the freeze-dried systems have a broader range hysteretic effect starting at 20% relative humidity. The results suggest that the internal structure of the MCC polymer fibers must change with the sorption and desorption of water, supporting the autohesion theory.


Subject(s)
Cellulose/chemistry , Excipients/chemistry , Adsorption , Chemistry, Pharmaceutical , Drug Compounding , Freeze Drying , Humidity
13.
J Clin Periodontol ; 19(5): 301-4, 1992 May.
Article in English | MEDLINE | ID: mdl-1517473

ABSTRACT

The aim of this study was to assess the effect of difference in tine diameter on probing pocket depth measurement. 2 sets of tines with Williams markings at 1, 2, 3, 5, 7, 8, 9 and 10 mm, and with a "round" tip, diameter 0.5 mm, were compared. One set was described as parallel-sided, the other as tapered. The parallel-sided tine was almost parallel from the 10 mm marking to the tip (tip diameter mean = 0.46 mm, 95% C.I. 0.456-0.464), while the corresponding diameter for the tapered tine varied (tip diameter mean = 0.48 mm, 95% C.I. 0.473-0.489). Calibration markings appeared highly consistent with the expected value to within 0.01 mm. The tines were mounted in Brodontic handles at 0.25 N. Examiner probing repeatability yielded kappa 0.86 for "parallel-sided" and 0.81 for "tapered" tines in vivo. 412 approximal pockets were assessed in 53 patients with routine chronic adult periodontitis, mean age 42.1 years. Each site had a probing depth of greater than or equal to 5 mm, PlI less than or equal to 1, GI less than or equal to 1, PBI less than or equal to 1. Each site was probed 2x with a 15-min interval. At the first 251 sites, the parallel-sided tine was used initially, and the tapered at the remaining 161 sites. Results indicated a highly significant tendency for the parallel-sided tine to yield a deeper reading when a difference occurred. These findings indicate that with adequate training providing high examiner repeatability, one source of error in probing data can be minimised.


Subject(s)
Periodontal Pocket/pathology , Periodontics/instrumentation , Adult , Calibration , Dental Plaque Index , Dental Prophylaxis , Equipment Design , Gingival Hemorrhage/pathology , Humans , Middle Aged , Oral Hygiene , Periodontal Index , Probability , Surface Properties
SELECTION OF CITATIONS
SEARCH DETAIL
...